Fredun Pharmaceuticals P/E Ratio

Current P/E Ratio
46.99
High Valuation
Very High - High growth expectations or significantly overvalued

Fredun Pharmaceuticals (FREDUN) P/E ratio is 46.99 (High), EPS (TTM) ₹66.81, current price ₹895.20 on BSE vs historical average P/E of 22.8 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see FREDUN share price.

Current Valuation Metrics

P/E Ratio 46.99
Current Price ₹895.20
EPS (TTM) ₹66.81
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 22.8
Historical Range 22.8 - 22.8
Percentile 100.0%

Sector Context

Sector Average 55.69
Sector Median 31.4
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹66.72
Mar 2026 ₹19.70
Sept 2025 ₹19.98

FREDUN P/E Ratio — Valuation Signal & Historical Context

Fredun Pharmaceuticals P/E 46.99 vs historical average 22.8, range 22.8–22.8 — signal: Overvalued. See Fredun Pharmaceuticals P/B ratio trends to compare market price against book value per share.

  • Stock appears overvalued with PE of 46.99, suggesting caution for new investments
  • Current PE is 106.1% above historical average
  • Trading at discount to sector average PE of 55.69

Fredun Pharmaceuticals P/E Ratio Historical Trend

FREDUN annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 46.99 vs historical average 22.8. Read FREDUN dividend yield for the complete payout history and dividend yield track record.

FREDUN Historical P/E Ratio — EPS, Year-End Price & Valuation

Fredun Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on BSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 22.8 69.21 ₹1578.30 BSE Moderate

FREDUN vs Healthcare Peers — P/E Ratio Comparison

Fredun Pharmaceuticals P/E 46.99 vs Healthcare average 55.69, median 31.4 — range 2.86–916.67.

Sector Average
55.69
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low